Drug
Torasemide Prolonged Release
Torasemide Prolonged Release: highest development phase Post-Market, developed by Ferrer. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Torasemide Prolonged Release (loop diuretic) NCT00334386 | Post-Market | Hypertension |
| Torasemide Prolonged Release NCT00409942 | Post-Market | Congestive Heart Failure |
Latest
No recent events.
Follow Torasemide Prolonged Release on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.